DK0796238T3 - Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik - Google Patents

Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik

Info

Publication number
DK0796238T3
DK0796238T3 DK95925889T DK95925889T DK0796238T3 DK 0796238 T3 DK0796238 T3 DK 0796238T3 DK 95925889 T DK95925889 T DK 95925889T DK 95925889 T DK95925889 T DK 95925889T DK 0796238 T3 DK0796238 T3 DK 0796238T3
Authority
DK
Denmark
Prior art keywords
fatty acids
pct
polyunsaturated fatty
cosmetics
therapy
Prior art date
Application number
DK95925889T
Other languages
English (en)
Inventor
Jean-Robert Grinda
Original Assignee
Grinda Jean Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grinda Jean Robert filed Critical Grinda Jean Robert
Application granted granted Critical
Publication of DK0796238T3 publication Critical patent/DK0796238T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/50—Use of additives, e.g. for stabilisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DK95925889T 1994-07-15 1995-07-17 Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik DK0796238T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408810A FR2722410B1 (fr) 1994-07-15 1994-07-15 Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique

Publications (1)

Publication Number Publication Date
DK0796238T3 true DK0796238T3 (da) 2000-10-02

Family

ID=9465440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95925889T DK0796238T3 (da) 1994-07-15 1995-07-17 Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik

Country Status (14)

Country Link
US (1) US5914347A (da)
EP (1) EP0796238B1 (da)
JP (1) JPH10508287A (da)
KR (1) KR100388818B1 (da)
AT (1) ATE193006T1 (da)
DE (1) DE69517050T2 (da)
DK (1) DK0796238T3 (da)
ES (1) ES2150004T3 (da)
FR (1) FR2722410B1 (da)
GR (1) GR3033990T3 (da)
MX (1) MX9701771A (da)
NZ (1) NZ289877A (da)
PT (1) PT796238E (da)
WO (1) WO1996002488A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
CA2627832C (en) * 1996-03-28 2012-12-11 Dsm Ip Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
DE112004001520B4 (de) * 2003-08-18 2008-04-10 Btg International Ltd. Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
DK2493296T3 (da) * 2009-10-30 2019-04-15 Retrotope Inc Lindring af oxidative stresstilstande med pufa-derivater
EP2708230A4 (en) * 2011-05-12 2014-12-03 Nippon Suisan Kaisha Ltd COMPOSITION FOR APPEARANCE ON THE SKIN FOR INFLAMMATORY DISEASES
AU2014358145C1 (en) 2013-12-04 2022-09-15 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
WO2017091279A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
US11779910B2 (en) 2020-02-21 2023-10-10 Biojiva Llc Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
JPS60258139A (ja) * 1984-06-05 1985-12-20 Nippon Oil & Fats Co Ltd 金属石けんの水分散体
FR2573653B1 (fr) * 1984-11-23 1988-02-26 Pf Medicament Compositions pharmaceutiques antiandrogenes a base d'acides gras
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid

Also Published As

Publication number Publication date
KR100388818B1 (ko) 2003-10-17
DE69517050D1 (de) 2000-06-21
PT796238E (pt) 2000-09-29
EP0796238A1 (fr) 1997-09-24
FR2722410A1 (fr) 1996-01-19
ES2150004T3 (es) 2000-11-16
GR3033990T3 (en) 2000-11-30
KR970706230A (ko) 1997-11-03
EP0796238B1 (fr) 2000-05-17
MX9701771A (es) 1997-12-31
NZ289877A (en) 1998-05-27
ATE193006T1 (de) 2000-06-15
JPH10508287A (ja) 1998-08-18
FR2722410B1 (fr) 1996-10-04
WO1996002488A1 (fr) 1996-02-01
US5914347A (en) 1999-06-22
DE69517050T2 (de) 2001-01-18

Similar Documents

Publication Publication Date Title
DK0796238T3 (da) Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik
ES2261446T3 (es) Utilizacion de una composicion que inhibe el crecimiento del pelo.
DE69927963D1 (de) Gelierbare pharmazeutische zusammensetzungen
NO971951D0 (no) Farmasöytiske preparater
JP4755985B2 (ja) 皮膚を美白にするおよび老人斑を処置するのための、ビオチンまたはビオチン誘導体の使用
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
BG106280A (en) Pharmacetical compositions containing fenofibrate and preparation method
KR20060027322A (ko) 세라미드 유형 화합물의 합성 방법
BR0009340A (pt) Composição adequada para uso na pele ou no cabelo, produto para aplicação na pele ou no cabelo, método para preparar uma composição adequada para aplicação na pele ou no cabelo, e, uso de uma composição
HUP9904360A2 (hu) Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával
GB2004741A (en) Cosmetic and pharmaceutical compositions for the skin
HUP0004981A2 (hu) Aminofenolszármazékot tartalmazó kozmetikai készítmény, ennek alkalmazása és eljárás aminofenol származékok oldására
HUP0001137A2 (hu) Bőrápoló szer
ES2103369T3 (es) Derivados de lanolina como sustancias que aceleran la penetracion y su aplicacion en sustancias farmaceuticas u otras formulaciones que contienen sustancias biologicamente activas.
ATE372760T1 (de) Stabilisierung oxidations-und/oder uv- empfindlicher wirkstoffe
JP2001302525A (ja) 皮膚外用剤
HUP9700842A1 (hu) Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
JP2007509994A (ja) アシルリボヌクレオシドおよびアシルデオキシリボヌクレオシド
JPH09157138A (ja) 養育毛剤
ATE213620T1 (de) Kosmetische zusammensetzungen enthaltend azelainsaure
JP2007022960A (ja) メラニン生成抑制剤及び美白化粧料
ES2172172T3 (es) Composiciones farmaceuticas solidas para la administracion por via oral que permiten la liberacion modulada de nicorandil y su procedimiento de preparacion.
Nyilas A new protecting group: 9-fluorenylmethoxycarbonyl (FMOC) in the synthesis of 1, 2-diacylglycerols
JPH02121904A (ja) 皮膚外用剤